Subscribe
shutterstock_1569668848_sundry_photography
Sundry Photography / Shutterstock.com
27 February 2020Big PharmaEdward Pearcey

China approves three Gilead remdesivir patents for COVID-19 treatment

US-based Gilead Sciences has been granted three Chinese patents connected to possible COVID-19 treatment remdesivir, reported He Zhimin, the deputy director of China’s National Intellectual Property Administration (CNIPA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Big Pharma
Novavax partners with Takeda to deliver COVID-19 vaccine in Japan
10 August 2020   US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.
Big Pharma
China unveils new drug patenting rules
11 February 2021   China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Big Pharma
Novavax partners with Takeda to deliver COVID-19 vaccine in Japan
10 August 2020   US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.
Big Pharma
China unveils new drug patenting rules
11 February 2021   China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

More on this story

Asia
Rouse and Codex launch new China partnership
4 June 2020   IP firm Rouse will collaborate with life sciences service provider Codex to support companies looking to enter the Chinese market.
Big Pharma
Novavax partners with Takeda to deliver COVID-19 vaccine in Japan
10 August 2020   US biotechnology company Novavax has signed a deal with Takeda Pharmaceuticals to develop, manufacture and market a COVID-19 vaccine in Japan, it was announced on Friday, August 7.
Big Pharma
China unveils new drug patenting rules
11 February 2021   China has introduced new measures to enforce a patent linkage system and proposed draft rules on how a patent owner can challenge the approval of a drug.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility